《風(fēng)濕病學(xué)雜志》于1974年首次出版，是由西爾弗曼伯爵編輯的國際期刊。該雜志以風(fēng)濕病學(xué)和相關(guān)領(lǐng)域的科學(xué)家發(fā)表的關(guān)于臨床課題的同行評審研究文章為特色，得到了我們尊敬的編輯委員會和編輯委員會的支持。根據(jù)加拿大基礎(chǔ)期刊的研究，風(fēng)濕病學(xué)雜志被列為風(fēng)濕病學(xué)的三大基礎(chǔ)出版物之一。事實上，74%的風(fēng)濕病學(xué)家認(rèn)為《風(fēng)濕病雜志》是一本必不可少的雜志，使其成為該專業(yè)的頂級雜志?！讹L(fēng)濕病學(xué)雜志》每月出版及時的臨床研究論文，包括印刷版和在線版?！讹L(fēng)濕病學(xué)雜志》每年引文數(shù)千篇，覆蓋全球3600多個訂閱者和加拿大風(fēng)濕病學(xué)協(xié)會所有活躍成員，包括風(fēng)濕病學(xué)居民和受訓(xùn)者?！讹L(fēng)濕病學(xué)雜志》的內(nèi)容自40多年前建立以來，一直與風(fēng)濕病學(xué)家密切相關(guān)，因為它強(qiáng)調(diào)持續(xù)性，同時接受創(chuàng)新?！讹L(fēng)濕病學(xué)雜志》每年有來自50多個國家的1600多篇論文提交，每期包括原始臨床研究文章、元分析、系統(tǒng)綜述、社論、歷史小插曲、病例報告和世界知名藥物治療專家的來信、患者報告的結(jié)果、發(fā)現(xiàn)治療目標(biāo)。在治療類風(fēng)濕關(guān)節(jié)炎、強(qiáng)直性脊柱炎、銀屑病關(guān)節(jié)炎、骨關(guān)節(jié)炎等風(fēng)濕性疾病和肌肉骨骼疾病方面?！讹L(fēng)濕病雜志》以加拿大和國外著名風(fēng)濕病學(xué)家在《風(fēng)濕病補(bǔ)充雜志》上發(fā)表的全國和國際會議或?qū)ｎ}討論會論文為特色。這些及時補(bǔ)充通常突出了有關(guān)風(fēng)濕性疾病機(jī)制的報告和新療法的最新進(jìn)展。

First published in 1974, The Journal of Rheumatology is a monthly international serial edited by Earl D. Silverman. The Journal features peer-reviewed research articles on clinical subjects from scientists working in rheumatology and related fields, with the support of our esteemed Editorial Committee and Editorial Board.According to The Canadian Essential Journal Study, The Journal of Rheumatology is ranked among the top 3 essential publications for rheumatology. In fact, 74% of rheumatologists consider The Journal of Rheumatology an essential journal, making it the top journal in the specialty.The Journal of Rheumatology publishes timely clinical research papers every month, both in print and online. With thousands of citations per year, The Journal of Rheumatology’s influence and reach extends to over 3600 subscribers globally and to all active members of the Canadian Rheumatology Association, including rheumatology residents and trainees. Since it was established over 40 years ago, The Journal of Rheumatology’s content remains highly relevant to rheumatologists because of the emphasis on continuity while embracing innovation.With over 1600 submissions a year from over 50 countries, each issue of The Journal of Rheumatology includes original clinical research articles, metaanalyses, systematic reviews, editorials, historical vignettes, case reports, and letters by world-renowned experts studying drug therapy, patient-reported outcomes, discovery of therapeutic targets in the treatment of rheumatic diseases such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, osteoarthritis, and other rheumatic and musculoskeletal diseases.The Journal of Rheumatology features proceedings of national and international conferences or symposia presented by renowned rheumatologists from Canada and abroad in The Journal of Rheumatology Supplements. These timely supplements typically highlight reports on the mechanisms of rheumatic diseases and updates on emerging therapies.